Medical Device News Magazine

Solvay Develops Industry-First Specialized UV-C Stabilizers for the Protection of Polyolefin Surfaces

About Medical Device News Magazine

About Medical Device News Magazine. We are a digital publication founded in 2008 located in the United States.

Advertise with Medical Device News Magazine! Join Our #1 Family of Advertisers!

We pride ourselves on being the best-kept secret when it comes to distributing your news! Our unique digital approach enables us to circulate your...

Solvay, a global market leader in specialty materials, has announced the development of an innovative new portfolio of UV-C stabilizers. They are designed for use in demanding hygiene applications, where polyolefin surfaces are treated with ultra-violet (UV) light of the UV-C spectrum (200-280 nm) to fight against COVID and hospital-acquired infections.

The new proprietary stabilization technology represents an important milestone for the polyolefin industry, as it is the first to address the risk of polyolefin degradation, discoloration and micro-crack formation, which is caused by frequent exposure to UV-C irradiation.

“Healthcare and other markets, such as aerospace and shared mobility, are increasingly using UV-C light to disinfect high-contact surfaces in an effort to combat pathogens, including coronaviruses,” says Sophie Poelmans, Global Marketing Manager for Polymer Additives at Solvay Materials. “Our new UV-C stabilization technology helps end-users achieve effective UV-C disinfection levels on surfaces made from polyolefins without compromising the performance of the material.”

UV-C radiation can deactivate microorganisms and has been scientifically proven to be effective against coronaviruses. However, the proven germicidal action of UV-C also exposes the treated surfaces to much higher ultraviolet energy than that covered by traditional UV-A and UV-B stabilizers, resulting in the potential for faster material degradation.

Solvay, a member of the International Ultraviolet Association (IUVA), has leveraged its extensive expertise in polymer additives to develop a technology that is purpose-engineered to enable the use of UV-C light as an anti-microbial disinfectant on polyolefin surfaces, while safely protecting them against UV-C induced degradation.

Solvay’s new UV-C stabilization technology is targeted at a wide range of polyolefin applications, including medical equipment in operation and patient rooms, aircraft and shared vehicle interiors, and sporting venues.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Other News

Shoulder Innovations Further Strengthens IP Portfolio in Key Areas with Recent Patent Grants

"These recent grants further strengthen key patent families that are foundational to our technology, and we are pleased the USPTO continues to recognize our meaningful innovation in the shoulder arthroplasty segment," said Rob Ball, CEO of Shoulder Innovations. "This noteworthy expansion of our IP position represents the culmination of over 10 years of research and development, and we are proud of our team for their continued dedication to creating practical solutions for shoulder surgeons and advancing patient outcomes."

Radical Catheter Technologies Presents Analysis of Disruptive, Recently FDA-Cleared Endovascular Technology at the Society of NeuroInterventional Surgery 21st Annual Meeting

This new catheter, the first product commercialized from this novel technology platform, is designed to enable access to the blood vessels in the brain for both femoral and radial access. A multi-center analysis of this disruptive technology is being presented today at Society of NeuroInterventional Surgery 21st annual meeting. In addition, the Company confirmed the closing of a $20 million financing round led by NeuroTechnology Investors, which will be used to scale the company and expand the Radical platform notes Radical Catheter Technologies.

Rapid Medical™ Completes Initial Neurovascular Cases in the USA Following FDA Clearance of Its Active Access Solution

“With DRIVEWIRE, our design goal was to bring new levels of access and control to the interventional suite while improving best-in-class guidewires,” comments Giora Kornblau, Chief Technology Officer at Rapid Medical. “When physicians are looking for technologies that increase the clinical possibilities and safety for the patient, we want Rapid to be the first place they look.”